Daniela Opriș-Belinski

Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders

Rheumatoid arthritis: pathogenesis and therapeutic advances

Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial

Harm, benefit and costs associated with low-dose glucocorticoids added to the treatment strategies for rheumatoid arthritis in elderly patients (GLORIA trial): study protocol for a randomised controlled trial